Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
Clinical trial NCT01113502 · TERMINATED
Trial details
- NCT number
- NCT01113502
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-03-14
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.